Australia Diabetes Medicine Sales is set to reach $723.63 Million by 2026 from $642.29 Million 2021, increased 5.9% per year. The country came in number 6 in 2021, South Korea came ahead $642.29 Million. Canada, Spain and Italy respectively were numbers 2, 3 and 4 in this ranking.
How does Australia rank in Diabetes Medicine Sales?
| # | 9 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Canada | 3,780 | 2023 | +14.14% | +15.25% | View data |
| 2 | 2 Italy | 1,450 | 2023 | +2.14% | +5.34% | View data |
| 3 | 3 Australia | 930 | 2023 | +10.37% | +10.77% | |
| 4 | 4 Croatia | 589.6 | 2023 | +2.47% | +3.43% | View data |
| 5 | 5 Portugal | 563.1 | 2023 | +3.89% | +8.21% | View data |
